生物活性 | |||
---|---|---|---|
描述 | Creatinine (NSC13123) is a byproduct of creatine phosphate breakdown in muscle, typically produced at a relatively stable rate by the body[1]. The measurement of creatinine levels in blood and urine is essential for calculating creatinine clearance (CrCl), which is indicative of the glomerular filtration rate (GFR), a crucial indicator of kidney function[2]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01756703 | Diabetic Nephropathy | Phase 2 | Completed | - | - |
NCT01113801 | Diabetic Kidney Disease ... 展开 >> Diabetic Nephropathy Diabetic Glomerulosclerosis 收起 << | Phase 2 | Terminated(Interim Assessment ... 展开 >>Lack of Efficacy) 收起 << | - | - |
NCT02955979 | - | Recruiting | December 2019 | France ... 展开 >> CHU de Lyon Recruiting Lyon, France, 69310 Contact: Etienne Javouhey, MD PhD (0)472129735 ext +33 etienne.javouhey@chu-lyon.fr Principal Investigator: Etienne Javouhey, MD PhD Sub-Investigator: Yves Gillet, MD PhD Chu Saint-Etienne Recruiting Saint Etienne, France, 42055 Contact: Olivier MORY, MD (0)477828632 ext +33 olivier.mory@chu-st-etienne.fr Principal Investigator: Olivier MORY, MD Sub-Investigator: Aymeric CANTAIS, MD Sub-Investigator: Hugues PATURAL, MD PhD 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
8.84mL 1.77mL 0.88mL |
44.20mL 8.84mL 4.42mL |
88.40mL 17.68mL 8.84mL |
参考文献 |
---|